UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 19, 2020
Accession Number:
Submission Type:
CIK:
0001600620
Company Name:
Aurinia Pharmaceuticals Inc.
File Number:
333-238785